References
- Artioli, G. G., Hirata, R. D. C., & Lancha Junior, A. H. (2007). Terapia gênica, doping genético e esporte: fundamentação e implicações para o futuro. Revista Brasileira de Medicina Do Esporte, 13(5), 349–354.
- Azzazy, H. M. E., Mansour, M. M. H., & Christenson, R. H. (2005). Doping in the recombinant era: Strategies and counterstrategies. Clinical Biochemistry, 38, 959–965.
- Baoutina, A., Alexander, I. E., Rasko, J. E. J., & Emslie, K. R. (2007). Potential use of gene transfer in athletic performance enhancement. Molecular Therapy, 15(10), 1751–1766. Retrieved from http://www.nature.com/mt/journal/v15/n10/full/6300278a.html
- Baoutina, A., Alexander, I. E., Rasko, J. E. J., & Emslie, K. R. (2008). Developing strategies for detection of gene doping. The Journal of Gene Medicine, 10, 3–20. Retrieved from http://onlinelibrary.wiley.com/doi/10.1002/jgm.1114/epdf
- Baoutina, A., Bhat, S., Zheng, M., Partis, L., Dobeson, M., Alexander, I. E., & Emslie, K. R. (2016). Synthetic certified DNA reference material for analysis of human erythropoietin transgene and transcript in gene doping and gene therapy. Gene Ther., 23(10), 708–717. Epub 2016 Jun 7.
- Baoutina, A., Coldham, T., Fuller, B., & Emslie, K. R. (2013). Improved detection of transgene and nonviral vectors in blood. Human Gene Therapy Methods, 24, 345–354.
- Barnard, M. (2001). Drug use in sports is not eradicable. In W. Dudley (Ed.), Drugs and sport (pp. 80–83). San Diego: Bender, David L.
- Baron, D. A., Martin, D. M., & Magd, S. A. (2007). Doping in sports and its spread to at-risk populations: An international review. World Psychiatry, 6, 118–123. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219897/
- Baron, D. A., Reardon, C. L., & Baron, S. H. (2013). Doping in sport. In Clinical sports psychiatry: An international perspective (pp. 21–32). Retrieved from http://www.wiley.com/WileyCDA/WileyTitle/productCd-1118404882.html
- Barros Neto, T. L. (2001). A Controvérsia dos Agentes Ergogênicos: Estamos Subestimando os Efeitos Naturais da Atividade Física? Arquivos Brasileiros de Endocrinologia & Metabologia, 45(2), 121–122. Retrieved from http://www.scielo.br/pdf/abem/v45n2/a02v45n2.pdf
- Beiter, T., Zimmermann, M., Fragasso, A., Armeanu, S., Lauer, U. M., Bitzer, M., … Simon, P. (2008). Establishing a novel single-copy primer-internal intron-spanning PCR (spiPCR) procedure for the direct detection of gene doping. Exercise Immunology Review, 14, 73–85.
- Beiter, T., Zimmermann, M., Fragasso, A., Hudemann, J., Niess, A. M., Bitzer, M., … Simon, P. (2011). Direct and long-term detection of gene doping in conventional blood samples. Gene Therapy, 18, 225–231.
- Bird, S. R., Goebel, C., Burke, L. M., & Greaves, R. F. (2016). Doping in sport and exercise: Anabolic, ergogenic, health and clinical issues. Annals of Clinical Biochemistry, 53(2), 196–221. Retrieved from http://acb.sagepub.com/content/53/2/196.full.pdf+html
- Bogdanov Jr, A. (2003). In vivo imaging in the development of gene therapy vectors. Current Opinion in Molecular Therapeutics, 5(6), 594–602. Retrieved from https://www.researchgate.net/publication/8891967_Bogdanov_AJr_In_vivo_imaging_in_the_development_of_gene_therapy_vectors_Curr_Opin_Mol_Ther_5_594-602
- Bowers, L. D., & Bigard, X. (2017). Achievements and challenges in anti-doping research. Medicine and Sport Science, 62, 77–90.
- Brzezianska, E., Domanska, D., & Jegier, A. (2014). Gene doping in sport - perspectives and risks. Biology of Sport, 31(4), 251–259. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25435666
- Carpenter, P. C. (2007). Performance-enhancing drugs in sport. Endocrinology and Metabolism Clinics of North America, 36, 481–495. Retrieved from http://www.sciencedirect.com/science/article/pii/S0889852907000230
- Chaturvedi, A., Chaturvedi, H., Kalra, J., & Kalra, S. (2007). Doping droops. Indian Journal of Physiology and Pharmacology, 51(2), 118–130. Retrieved from http://www.ijpp.com/IJPP archives/2007_51_2/118-130.pdf
- Chenuaud, P., Larcher, T., Rabinowitz, J. E., Provost, N., Cherel, Y., Casadevall, N., … Moullier, P. (2004). Autoimmune anemia in macaques following erythropoietin gene therapy. Blood Journal, 103(9), 3303–3304. Retrieved from http://www.bloodjournal.org/content/103/9/3303.long?sso-checked=true
- De Rose, E. H. (2008). Doping in athletes - an update. Clinics in Sports Medicine, 27, 107–130. Retrieved from http://www.sciencedirect.com/science/article/pii/S0278591907000919
- Diamanti-Kandarakis, E., Konstantinopoulos, P. A., Papailiou, J., Kandarakis, S. A., Andreopoulos, A., & Sykiotis, G. P. (2005). Erythropoietin abuse and erythropoietin gene doping. Sports Medicine, 35(10), 831–840. Retrieved from https://www.researchgate.net/publication/7583079_Erythropoietin_abuse_and_erythropoietin_gene_doping_Detection_strategies_in_the_genomic_era
- Dunbar, C. E., High, K. A., Joung, J. K., Ozawa, K., & Sadelain, M. (2018). Gene therapy comes of age. Science, 359(175). doi: 10.1126/science.aan4672
- Durussel, J., Haile, D. W., Mooses, K., Daskalaki, E., Beattie, W., Mooses, M., … Pitsiladis, Y. P. (2016). Blood transcriptional signature of recombinant human erythropoietin administration and implications for antidoping strategies. Physiological Genomics, 48, 202–209.
- Fears, R., & Meulen, V. T. (2017). How should the applications of genome editing be assessed and regulated? Elife, 6, 26295. doi:10.7554/eLife.26295.
- Fellmann, C., Gowen, B. G., Lin, P.-C., Doudna, J. A., & Corn, J. E. (2017). Cornerstones of CRISPR-Cas in drug development and therapy. Nature Reviews Drug Discovery, 16(2), 89–100.
- Franceshini, M. (2017). Cientista russo-australiana descobre técnica revolucionária para flagrar doping genético. Brasil: Planeta SporTV, Globo. Retrieved from http://sportv.globo.com/videos/planeta-sportv/v/cientista-russo-australiana-descobre-tecnica-revolucionaria-para-flagrar-doping-genetico/5785315/
- Gaffney, G. R., & Parisotto, R. (2007). Gene doping: A review of performance-enhancing genetics. Pediatric Clinics of North America, 54, 807–822. Retrieved from http://www.sciencedirect.com/science/article/pii/S0031395507000636
- Gerlinger, K., Petermann, T., & Sauter, A. (2009). Gene Doping. Scientific Basis – Gateways – Monitoring. Report for the Committee on Education, Research and Technology Assessment. Technology Assessment Studies Series, n. 3.
- Haisma, H. J., & de Hon, O. (2006). Gene doping. International Journal of Sports Medicine, 27, 257–266.
- Hakimi, P., Yang, J., Casadesus, G., Massillon, D., Tolentino-Silva, F., Nye, C. K., … Hanson, R. W. (2007). Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse. Journal of Biological Chemistry, 282, 32844–32855.
- Hoberman, J. (1992). Mortal engines: The science of performance and deshumanization of sport. New York: Free Press.
- Huard, J., Li, Y., Peng, H., & Fu, F. H. (2003). Gene therapy and tissue engineering for sports medicine. The Journal of Gene Medicine, 5, 93–108. Retrieved from http://onlinelibrary.wiley.com/doi/10.1002/jgm.344/pdf
- IAAF. (2016). IAAF commitment to healthy and drug-free athletics. Retrieved from https://www.iaaf.org/about-iaaf/medical-anti-doping
- Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012). A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity. Science, 337(6096), 816–821.
- Karthikeyan, B. V., & Pradeep, A. R. (2006). Gene therapy in periodontics: A review and future implications. The Journal of Contemporary Dental Practice, 7(3), 83–91. Retrieved from https://www.researchgate.net/publication/6963813_Gene_therapy_in_periodontics_A_review_and_future_implications
- Kumar, S. (2013). Performance enhancinhg drugs in sports. Vignettes of Research, 1(4), 164–169. Retrieved from http://www.researchjournals.in/ALL/VOR/2013/1.4/1422.pdf
- Lander, E. S., Baylis, F., Zhang, F., Charpentier, E., Berg, P., Bourgain, C., … Winnacker, E. L. (2019). Adopt a moratorium on heritable genome editing. Nature, 567, 165–168.
- Lasne, F., Martin, L., de Ceaurriz, J., Larcher, T., Moullier, P., & Chenuaud, P. (2004). “Genetic Doping” with erythropoietin cDNA in primate muscle is detectable. Molecular Therapy, 10(3), 409–410. Retrieved from http://www.nature.com/mt/journal/v10/n3/full/mt20041242a.html
- Mashimo, T. (2014). Gene targeting technologies in rats: Zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats. Development, Growth & Differentiation, 56, 46–52.
- Miah, A. (2012). Genetics & sport: Bioethical concerns. Recent Patents on DNA & Gene Sequence, 6, 197–202. Retrieved from http://www.eurekaselect.com/101640/article
- Moser, D. A., Neuberger, E. W. I., & Simon, P. (2012). A quick one-tube nested PCR-protocol for EPO transgene detection. Drug Testing and Analysis, 4, 870–875.
- Neuberger, E. W. I., Perez, I., Le Guiner, C., Moser, D., Ehlert, T., Allais, M., … Snyder, R. O. (2016). Establishment of two quantitative nested qPCR assays targeting the human EPO transgene. Gene Therapy, 23(4), 330–339.
- Neuberger, E. W. I., & Simon, P. (2017). Gene and cell doping: The new frontier - beyond myth or reality. Medicine and Sport Science, 62, 91–106.
- Ni, W., Le Guiner, C., Gernoux, G., Penaud-Budloo, M., Moullier, P., & Snyder, R. O. (2011). Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: Implications for gene doping. Gene Therapy, 18, 709–718.
- Ormond, K. E., Mortlock, D. P., Scholes, D. T., Bombard, Y., Brody, L. C., Faucerr, W. A., … Young, C. E. (2017). Human germline genome editing. The American Journal of Human Genetics, 101, 167–176.
- Peñuelas, I., Boán, J. F., Martí-Climent, J. M., Sangro, B., Mazzolini, G., Prieto, J., & Richter, J. A. (2004). Positron emission tomography and gene therapy: Basic concepts and experimental approaches for In Vivo gene expression imaging. Molecular Imaging and Biology, 6(4), 225–238.
- Pokrywka, A., Kaliszewski, P., Majorczyk, E., & Zembrón-Lacny, A. (2013). Genes is sport and doping. Biology of Sport, 30(3), 155–161. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944571/
- Reardon, C. L., & Creado, S. (2014). Drug abuse in athletes. Substance Abuse and Rehabilitation, 5, 95–105. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140700/pdf/sar-5-095.pdf
- Salamin, O., Kuuranne, T., Saugy, M., & Leuenberger, N. (2017). Loop-mediated isothermal amplification (LAMP) as an alternative to PCR: A rapid on-site detection of gene doping. Drug Testing and Analysis, 9, 1731–1737.
- Solomon, L. M., Mordkoff, D. S., & Noll, R. C. (2009). Physical enhancement of human performance: Is law keeping pace with science? Gender Medicine, 6(1), 249–258. Retrieved from http://www.sciencedirect.com/science/article/pii/S1550857909000412
- Teale, P., Barton, C., Driver, P. M., & Kay, R. G. (2009). Biomarkers: Unrealized potential in sports doping analysis. Bioanalysis, 1(6), 1103–1118. Retrieved from http://www.future-science.com/doi/pdf/10.4155/bio.09.87
- Thevis, M., Kuuranne, T., Geyer, H., & Schänzer, W. (2014). Annual banned-substance review: Analytical approaches in human sports drug testing. Drug Testind and Analysis. Retrieved from http://onlinelibrary.wiley.com/doi/10.1002/dta.2139/pdf
- Thomas, A., Walpurgis, K., Delahaut, P., Kohler, M., Schänzer, W., & Thevis, M. (2013). Detection of small interfering RNA (siRNA) by mass spectrometry procedures in doping controls. Drug Testing and Analysis. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23913913
- Todd, J., & Todd, T. (2001). Significant events in the history of drug testing and the Olympic movement: 1960–1999. In Doping in elite sport (pp. 65–128). Retrieved from https://www.peacepalacelibrary.nl/plinklet/index.php?ppn=301110883
- van der Gronde, T., de Hon, O., Haisma, H. J., & Pieters, T. (2013). Gene doping: An overview and current implications for athletes. British Journal of Sports Medicine, 47(11), 670–678.
- Verroken, M. (2005). Drug use and abuse in sport. In D. R. Mottram (Ed.), Drugs in sport (4th ed., pp. 29–63). Nova York: Routledge.
- WADA. (2009). WADA at a glance. Retrieved from https://www.wada-ama.org/sites/default/files/resources/files/WADA_PK_WADA_at_a_Glance_2009_EN.pdf
- WADA. (2019). WADA Prohibited List 2019.
- WADA Prohibited List. (2019). https://www.wada-ama.org/sites/default/files/wada_2019_english_prohibited_list.pdf.
- Wang, G., Durussel, J., Shulock, J., Mooses, M., Fuku, N., Bruinvels, G., … Pitsiladis, Y. P. (2017). Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration. BMC Genomics, 18, 67–80.
- Ye, X., Rivera, V. M., Zoltick, P., Cerasoli Jr, F., Schnell, M. A., Gao, G., … Wilson, J. M. (1999). Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science, 283, 88–91. Retrieved from http://science.sciencemag.org/content/283/5398/88
- Yesalis, C. E., & Bahrke, M. S. (2002). History of doping in sport. International Sports Studies, 24(1), 42–76. Retrieved from http://library.la84.org/SportsLibrary/ISS/ISS2401/ISS2401e.pdf